Pietari Ripatti Selected Research

Lipids

12/2020	Effects of TM6SF2 E167K on hepatic lipid and very low-density lipoprotein metabolism in humans.
1/2020	Polygenic Hyperlipidemias and Coronary Artery Disease Risk.
1/2016	The Contribution of GWAS Loci in Familial Dyslipidemias.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pietari Ripatti Research Topics

Disease

3	Hypercholesterolemia 12/2023 - 01/2020
3	Genetic Risk Score 12/2023 - 01/2020
3	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2022 - 01/2019
2	Coronary Artery Disease (Coronary Atherosclerosis) 12/2023 - 01/2019
2	Coronary Disease (Coronary Heart Disease) 12/2023 - 01/2016
1	Myocardial Ischemia (Ischemic Heart Diseases) 12/2023
1	Heart Diseases (Heart Disease) 12/2023
1	Fatty Liver 01/2022
1	Non-alcoholic Fatty Liver Disease 12/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2020
1	Hypertriglyceridemia 01/2020
1	Hyperlipidemias (Hyperlipidemia) 01/2019
1	Familial Combined Hyperlipidemia (Combined Hyperlipidemia, Familial) 01/2016
1	Dyslipidemias (Dyslipidemia) 01/2016

Drug/Important Bio-Agent (IBA)

4	LDL CholesterolIBA 12/2023 - 01/2019
4	Triglycerides (Triacylglycerol)IBA 01/2022 - 01/2016
3	oxidized low density lipoproteinIBA 01/2022 - 01/2019
3	LipidsIBA 12/2020 - 01/2016
2	CholesterolIBA 12/2023 - 01/2016
2	Lipoproteins (Lipoprotein)IBA 12/2023 - 01/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2023
1	Biomarkers (Surrogate Marker)IBA 12/2023
1	Apolipoproteins B (ApoB)IBA 12/2023
1	Phospholipases (Phospholipase)IBA 01/2022
1	LDL Receptors (LDL Receptor)IBA 01/2019